{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:31:56Z","timestamp":1787059916933,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"DOI":"10.1007\/s40264-026-01714-1","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:21:49Z","timestamp":1787059309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antiemetic Combination Use During the First Trimester and Adverse Circulatory Outcomes in Newborn Infants: A Data-Mining Analysis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4544-1160","authenticated-orcid":false,"given":"Thuy N.","family":"Thai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith C.","family":"Maro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja A.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almut G.","family":"Winterstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"issue":"2","key":"1714_CR1","first-page":"e171","volume":"20","author":"TR Einarson","year":"2013","unstructured":"Einarson TR, Piwko C, Koren G. Quantifying the global rates of nausea and vomiting of pregnancy: a meta analysis. J Popul Ther Clin Pharmacol. 2013;20(2):e171\u201383.","journal-title":"J Popul Ther Clin Pharmacol"},{"issue":"10","key":"1714_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.40414","volume":"7","author":"TN Thai","year":"2024","unstructured":"Thai TN, Brown J, Schmidt S, Maro J, Rasmussen SA, Winterstein AG. Use of prescription antiemetics among US commercially insured pregnant patients, 2005-2019. JAMA Netw Open. 2024;7(10):e2440414. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.40414.","journal-title":"JAMA Netw Open"},{"key":"1714_CR3","doi-asserted-by":"publisher","unstructured":"Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 189: nausea and vomiting of pregnancy. Obstet Gynecol. 2018;131(1):e15\u201330. https:\/\/doi.org\/10.1097\/AOG.0000000000002456.","DOI":"10.1097\/AOG.0000000000002456"},{"key":"1714_CR4","unstructured":"Woosley R, Heise C, Romero K. QTdrugs List. Published online March 4, 2020. Available from: https:\/\/www.crediblemeds.org\/. Accessed 7 Aug 2026."},{"issue":"1","key":"1714_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-15761-8","volume":"15","author":"C Alvarez Baron","year":"2025","unstructured":"Alvarez Baron C, Zhao J, Yu H, et al. Multi-laboratory comparisons of manual patch clamp hERG data generated using standardized protocols and following ICH S7B Q&A 2.1 best practices. Sci Rep. 2025;15(1):29995. https:\/\/doi.org\/10.1038\/s41598-025-15761-8.","journal-title":"Sci Rep"},{"issue":"1","key":"1714_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000083234","volume":"74","author":"S Claassen","year":"2005","unstructured":"Claassen S, Z\u00fcnkler BJ. Comparison of the effects of metoclopramide and domperidone on HERG channels. Pharmacology. 2005;74(1):31\u20136. https:\/\/doi.org\/10.1159\/000083234.","journal-title":"Pharmacology"},{"issue":"5","key":"1714_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.phrs.2009.05.008","volume":"60","author":"SH Jo","year":"2009","unstructured":"Jo SH, Hong HK, Chong SH, Lee HS, Choe H. H(1) antihistamine drug promethazine directly blocks hERG K(+) channel. Pharmacol Res. 2009;60(5):429\u201337. https:\/\/doi.org\/10.1016\/j.phrs.2009.05.008.","journal-title":"Pharmacol Res"},{"key":"1714_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.reprotox.2019.06.002","volume":"87","author":"HE Ritchie","year":"2019","unstructured":"Ritchie HE, Huss IB, Webster WS. The effect of anti-emetic drugs on rat embryonic heart activity. Reprod Toxicol. 2019;87:140\u20135. https:\/\/doi.org\/10.1016\/j.reprotox.2019.06.002.","journal-title":"Reprod Toxicol"},{"key":"1714_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00287","volume":"5","author":"M Midgett","year":"2014","unstructured":"Midgett M, Rugonyi S. Congenital heart malformations induced by hemodynamic altering surgical interventions. Front Physiol. 2014;5:287. https:\/\/doi.org\/10.3389\/fphys.2014.00287.","journal-title":"Front Physiol"},{"key":"1714_CR10","unstructured":"National Heart, Lung, and Blood Institute. Cardiomyopathy. Available from: https:\/\/www.nhlbi.nih.gov\/health-topics\/cardiomyopathy. Accessed 7 Aug 2026."},{"issue":"19","key":"1714_CR11","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1056\/NEJM198805123181907","volume":"318","author":"P Nicod","year":"1988","unstructured":"Nicod P, Polikar R, Peterson KL. Hypertrophic cardiomyopathy and sudden death. N Engl J Med. 1988;318(19):1255\u20137. https:\/\/doi.org\/10.1056\/NEJM198805123181907.","journal-title":"N Engl J Med"},{"issue":"7","key":"1714_CR12","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1161\/01.cir.65.7.1388","volume":"65","author":"BJ Maron","year":"1982","unstructured":"Maron BJ, Roberts WC, Epstein SE. Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation. 1982;65(7):1388\u201394. https:\/\/doi.org\/10.1161\/01.cir.65.7.1388.","journal-title":"Circulation"},{"issue":"14","key":"1714_CR13","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/0002-9149(87)90406-1","volume":"60","author":"P Spirito","year":"1987","unstructured":"Spirito P, Watson RM, Maron BJ. Relation between extent of left ventricular hypertrophy and occurrence of ventricular tachycardia in hypertrophic cardiomyopathy. Am J Cardiol. 1987;60(14):1137\u201342. https:\/\/doi.org\/10.1016\/0002-9149(87)90406-1.","journal-title":"Am J Cardiol"},{"issue":"2","key":"1714_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/heart.88.2.153","volume":"88","author":"X Jouven","year":"2002","unstructured":"Jouven X, Hagege A, Charron P, et al. Relation between QT duration and maximal wall thickness in familial hypertrophic cardiomyopathy. Heart. 2002;88(2):153\u20137. https:\/\/doi.org\/10.1136\/heart.88.2.153.","journal-title":"Heart"},{"key":"1714_CR15","unstructured":"Kulldorff M. TreeScan software for the tree-based scan statistic. Available from: https:\/\/www.treescan.org\/. Accessed 21 Jun 2026."},{"issue":"2","key":"1714_CR16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/1541-0420.00039","volume":"59","author":"M Kulldorff","year":"2003","unstructured":"Kulldorff M, Fang Z, Walsh SJ. A tree-based scan statistic for database disease surveillance. Biometrics. 2003;59(2):323\u201331. https:\/\/doi.org\/10.1111\/1541-0420.00039.","journal-title":"Biometrics"},{"issue":"5","key":"1714_CR17","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/pds.3423","volume":"22","author":"M Kulldorff","year":"2013","unstructured":"Kulldorff M, Dashevsky I, Avery TR, et al. Drug safety data mining with a tree-based scan statistic. Pharmacoepidemiol Drug Saf. 2013;22(5):517\u201323. https:\/\/doi.org\/10.1002\/pds.3423.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1714_CR18","unstructured":"Medicaid & CHIP coverage. Available from: https:\/\/www.healthcare.gov\/medicaid-chip\/. Accessed 14 Jun 2026."},{"key":"1714_CR19","first-page":"1","volume":"468","author":"CP Valenzuela","year":"2023","unstructured":"Valenzuela CP, Osterman MJK. Characteristics of mothers by source of payment for the delivery: United States, 2021. NCHS Data Brief. 2023;468:1\u20138.","journal-title":"NCHS Data Brief"},{"key":"1714_CR20","unstructured":"Merative. MarketScan Research Databases. Available from: https:\/\/assets.merative.com\/m\/4e9e9971589b0f0f\/original\/MarketScan_Merative-MarketScan-Research-Databases_Solution-Brief.PDF. Accessed 14 Jun 2026."},{"key":"1714_CR21","unstructured":"Centers for Medicare & Medicaid Services. Medicaid Analytic eXtract (MAX) general information. Available from: https:\/\/www.cms.gov\/data-research\/computer-data-systems\/medicaid-data-sources-general-information\/medicaid-analytic-extract-max-general-information. Accessed 14 Jun 2026."},{"issue":"11","key":"1714_CR22","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s40264-021-01113-8","volume":"44","author":"K Moll","year":"2021","unstructured":"Moll K, Wong HL, Fingar K, et al. Validating claims-based algorithms determining pregnancy outcomes and gestational age using a linked claims-electronic medical record database. Drug Saf. 2021;44(11):1151\u201364. https:\/\/doi.org\/10.1007\/s40264-021-01113-8.","journal-title":"Drug Saf"},{"issue":"12","key":"1714_CR23","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.2147\/CLEP.S269400","volume":"2020","author":"A Sarayani","year":"2020","unstructured":"Sarayani A, Wang X, Thai TN, Albogami Y, Jeon N, Winterstein AG. Impact of the transition from ICD-9-CM to ICD-10-CM on the identification of pregnancy episodes in US health insurance claims data. Clin Epidemiol. 2020;2020(12):1129\u201338. https:\/\/doi.org\/10.2147\/CLEP.S269400.","journal-title":"Clin Epidemiol"},{"issue":"Suppl. 2","key":"1714_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/pds.4864","volume":"28","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Thai TN, Bateman BT, et al. Development and validation of algorithms to estimate live birth gestational age in Medicaid analytic extract data. Pharmacoepidemiol Drug Saf. 2019;28(Suppl. 2):235. https:\/\/doi.org\/10.1002\/pds.4864.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"1714_CR25","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1002\/pds.4843","volume":"28","author":"CA Knox","year":"2019","unstructured":"Knox CA, Hampp C, Palmsten K, et al. Validation of mother-infant linkage using Medicaid case ID variable within the Medicaid analytic eXtract (MAX) database. Pharmacoepidemiol Drug Saf. 2019;28(9):1222\u201330. https:\/\/doi.org\/10.1002\/pds.4843.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1714_CR26","doi-asserted-by":"publisher","unstructured":"Multifetal gestations: twin, triplet, and higher-order multifetal pregnancies: ACOG Practice Bulletin, Number 231. Obstet Gynecol. 2021;137(6):e145\u201362. https:\/\/doi.org\/10.1097\/AOG.0000000000004397.","DOI":"10.1097\/AOG.0000000000004397"},{"issue":"10","key":"1714_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2024.101440","volume":"6","author":"R Atwani","year":"2024","unstructured":"Atwani R, Aziz M, Saade G, Reddy U, Kawakita T. Maternal implications of fetal anomalies: a population-based cross-sectional study. Am J Obstet Gynecol MFM. 2024;6(10):101440. https:\/\/doi.org\/10.1016\/j.ajogmf.2024.101440.","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"12","key":"1714_CR28","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/pds.4082","volume":"25","author":"X Liu","year":"2016","unstructured":"Liu X, Kubilis P, Bussing R, Winterstein AG. Development of a refill pattern method to measure polypharmacy in administrative claims databases. Pharmacoepidemiol Drug Saf. 2016;25(12):1407\u201313. https:\/\/doi.org\/10.1002\/pds.4082.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1714_CR29","unstructured":"Hikma Pharmaceuticals USA Inc. Phenergan: promethazine hydrochloride injection. June 2009. Available from: https:\/\/dailymed.nlm.nih.gov\/dailymed\/lookup.cfm?setid=481866da-a712-48a5-853f-8e84aacaab6d. Accessed 14 Jun 2026."},{"key":"1714_CR30","unstructured":"ANI Pharmaceuticals, Inc. Reglan\u00ae (metoclopramide) tablets, for oral use. August 2017. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/017854s062lbl.pdf. Accessed 14 Jun 2026."},{"key":"1714_CR31","unstructured":"GlaxoSmithKline. Zofran (ondansetron hydrochloride) tablets, for oral use. October 2016. Available from: ohttps:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/020103s035_020605s019_020781s019lbl.pdf. Accessed 21 Jun 2026."},{"key":"1714_CR32","unstructured":"Agency for Healthcare Research and Quality. Clinical Classifications Software (CCS) for ICD-9-CM. March 6, 2017. Available from: https:\/\/hcup-us.ahrq.gov\/toolssoftware\/ccs\/ccs.jsp. Accessed 20 Sep 2024."},{"issue":"8","key":"1714_CR33","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1093\/aje\/kwag060","volume":"195","author":"TN Thai","year":"2026","unstructured":"Thai TN, Smolinski NE, Rasmussen SA, et al. A new tool for pregnancy research: a unified definition for major congenital malformation across ICD eras. Am J Epidemiol. 2026;195(8):2244\u201352. https:\/\/doi.org\/10.1093\/aje\/kwag060.","journal-title":"Am J Epidemiol"},{"key":"1714_CR34","unstructured":"Agency for Healthcare Research and Quality. Archives for previous beta versions of the CCS for ICD-10-CM diagnoses. Available from: https:\/\/www.hcup-us.ahrq.gov\/toolssoftware\/ccsr\/ccsr_archive.jsp#ccsbeta. Accessed 21 Jun 2026."},{"key":"1714_CR35","unstructured":"Centers for Medicare & Medicaid Services. ICD-10 files & news archive. September 24, 2024. Available from: https:\/\/www.cms.gov\/medicare\/coding-billing\/icd-10-codes\/icd-10-cm-icd-10-pcs-gem-archive. Accessed 1 Nov 2024."},{"issue":"1","key":"1714_CR36","doi-asserted-by":"publisher","DOI":"10.5334\/egems.225","volume":"5","author":"JC Maro","year":"2017","unstructured":"Maro JC, Nguyen MD, Dashevsky I, Baker MA, Kulldorff M. Statistical power for postlicensure medical product safety data mining. EGEMS (Wash DC). 2017;5(1):6. https:\/\/doi.org\/10.5334\/egems.225.","journal-title":"EGEMS (Wash DC)"},{"key":"1714_CR37","unstructured":"Yih WK, Maro JC, Dashevsky I, et al. Sentinel CBER surveillance protocol: evaluation of HPV9 (Gardasil 9) vaccine safety surveillance using the TreeScan data mining method. Published online June 30, 2016. Available from: https:\/\/www.sentinelinitiative.org\/sites\/default\/files\/vaccines-blood-biologics\/assessments\/Sentinel_PRISM_HPV9-Vaccine-Safety-Surveillance-Using-TreeScan.pdf. Accessed 7 Aug 2026."},{"key":"1714_CR38","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.csda.2013.10.018","volume":"72","author":"JM Franklin","year":"2014","unstructured":"Franklin JM, Schneeweiss S, Polinski JM, Rassen JA. Plasmode simulation for the evaluation of pharmacoepidemiologic methods in complex healthcare databases. Comput Stat Data Anal. 2014;72:219\u201326. https:\/\/doi.org\/10.1016\/j.csda.2013.10.018.","journal-title":"Comput Stat Data Anal"},{"issue":"2","key":"1714_CR39","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/pds.5512","volume":"32","author":"EA Suarez","year":"2023","unstructured":"Suarez EA, Nguyen M, Zhang D, et al. Novel methods for pregnancy drug safety surveillance in the FDA sentinel system. Pharmacoepidemiol Drug Saf. 2023;32(2):126\u201336. https:\/\/doi.org\/10.1002\/pds.5512.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"1714_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2023.101245","volume":"6","author":"Y Wang","year":"2024","unstructured":"Wang Y, Smolinski NE, Thai TN, et al. Common teratogenic medication exposures-a population-based study of pregnancies in the United States. Am J Obstet Gynecol MFM. 2024;6(1):101245. https:\/\/doi.org\/10.1016\/j.ajogmf.2023.101245.","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"3","key":"1714_CR41","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399\u2013424. https:\/\/doi.org\/10.1080\/00273171.2011.568786.","journal-title":"Multivariate Behav Res"},{"issue":"3","key":"1714_CR42","doi-asserted-by":"publisher","first-page":"263.e1","DOI":"10.1016\/j.ajog.2019.09.004","volume":"222","author":"BF Cuneo","year":"2020","unstructured":"Cuneo BF, Kaizer AM, Clur SA, et al. Mothers with long QT syndrome are at increased risk for fetal death: findings from a multicenter international study. Am J Obstet Gynecol. 2020;222(3):263.e1-e11. https:\/\/doi.org\/10.1016\/j.ajog.2019.09.004.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"1714_CR43","first-page":"285","volume":"45","author":"CPH Ibrahim","year":"2008","unstructured":"Ibrahim CPH. Hypotension in preterm infants. Indian Pediatr. 2008;45(4):285\u201394.","journal-title":"Indian Pediatr"},{"issue":"9","key":"1714_CR44","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/pds.4794","volume":"28","author":"SC MacDonald","year":"2019","unstructured":"MacDonald SC, Cohen JM, Panchaud A, McElrath TF, Huybrechts KF, Hern\u00e1ndez-D\u00edaz S. Identifying pregnancies in insurance claims data: methods and application to retinoid teratogenic surveillance. Pharmacoepidemiol Drug Saf. 2019;28(9):1211\u201321. https:\/\/doi.org\/10.1002\/pds.4794.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"1714_CR45","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/EDE.0000000000001561","volume":"34","author":"EA Suarez","year":"2023","unstructured":"Suarez EA, Nguyen M, Zhang D, et al. Monitoring drug safety in pregnancy with scan statistics: a comparison of two study designs. Epidemiology. 2023;34(1):90\u20138. https:\/\/doi.org\/10.1097\/EDE.0000000000001561.","journal-title":"Epidemiology"},{"issue":"6","key":"1714_CR46","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/EDE.0000000000000907","volume":"29","author":"SV Wang","year":"2018","unstructured":"Wang SV, Maro JC, Baro E, et al. Data mining for adverse drug events with a propensity score-matched tree-based scan statistic. Epidemiology. 2018;29(6):895\u2013903. https:\/\/doi.org\/10.1097\/EDE.0000000000000907.","journal-title":"Epidemiology"},{"issue":"2","key":"1714_CR47","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/sim.3780","volume":"29","author":"L Li","year":"2010","unstructured":"Li L, Kulldorff M. A conditional maximized sequential probability ratio test for pharmacovigilance. Stat Med. 2010;29(2):284\u201395. https:\/\/doi.org\/10.1002\/sim.3780.","journal-title":"Stat Med"},{"issue":"12","key":"1714_CR48","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1093\/aje\/kwae151","volume":"193","author":"TN Thai","year":"2024","unstructured":"Thai TN, Winterstein AG, Suarez EA, et al. Triple challenges: small sample size in both exposure and control groups to scan rare maternal outcomes in a signal identification approach: a simulation study. Am J Epidemiol. 2024;193(12):1805\u201313. https:\/\/doi.org\/10.1093\/aje\/kwae151.","journal-title":"Am J Epidemiol"},{"key":"1714_CR49","doi-asserted-by":"publisher","unstructured":"Thai TN, Brown J, Schmidt S, Maro JC, Rasmussen SA, Winterstein AG. Evaluating the safety of antiemetic combination use on pregnancy loss. In: Abstracts of ICPE 2022. 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE); 26\u201328 August, 2022; Copenhagen: 2022;31(S2). https:\/\/doi.org\/10.1002\/pds.5518.","DOI":"10.1002\/pds.5518"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-026-01714-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-026-01714-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-026-01714-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:21:51Z","timestamp":1787059311000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-026-01714-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":49,"alternative-id":["1714"],"URL":"https:\/\/doi.org\/10.1007\/s40264-026-01714-1","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"22 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The views expressed in this article are those of the authors and do not necessarily represent the official position of the Florida Department of Health.","order":1,"name":"Ethics","label":"Disclaimer","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sonja A. Rasmussen receives consulting fees from pharmaceutical companies (i.e., Pfizer, Axsome Therapeutics, Harmony Biosciences, Myovant, and Novo Nordisk) for work on scientific advisory committees for pregnancy registries. Judith C. Maro has received research funding from the National Institutes of Health, Pfizer, US Food and Drug Administration, and Centers for Disease Control and Prevention. Almut G. Winterstein has received research funding from Merck, Sharpe and Dohme, National Institutes of Health, Agency for Healthcare Research and Quality, Patient-Centered Outcomes Research Institute, US Food and Drug Administration, the Bill and Melinda Gates Foundation, and the State of Florida and received consulting fees from Arbor Pharmaceuticals, Bayer, Ipsen, Novo Nordisk, Lykos, Syneos, and Genentech Inc, none of which is related to this work. Almut G. Winterstein is an Editorial Board member of\n                      Drug Safety\n                      . Almut G. Winterstein was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Thuy N. Thai, Joshua Brown, and Stephan Schmidt have no conflicts of interest that are directly relevant to the content of this article.","order":2,"name":"Ethics","label":"Conflict of interest\/Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review and Privacy Boards of the University of Florida (IRB202301981), the Florida Department of Health (DUA2018064), and the Centers for Medicare and Medicaid Services (DUA 52331).","order":3,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All data supporting the findings of this study are available within the article and its supplementary information file.","order":6,"name":"Ethics","label":"Availability of Data and Material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The programming codes are not publicly available.","order":7,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TNT, JCM, JB, SS, SAR, and AGW contributed to the study conception and design. Data acquisition was performed by AGW. Data analysis and interpretation were conducted by TNT. TNT drafted the initial manuscript. All authors contributed to revising the manuscript and read and approved the final manuscript.","order":8,"name":"Ethics","label":"Authors\u2019 Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}